Risk factors and incidence of pneumonitis in NSCLC patient treated with chemoradiotherapy and Durvalumab: A comparative analysis with a non-Durvalumab cohort (PraDa)

Respiratory Medicine and Research · Elsevier

Аннотация

Publication date: November 2026 Source: Respiratory Medicine and Research, Volume 90 Author(s): Julien Swiderski, Cécile Evin, François Durand-Hardy, Thomas Duroy, Emilie Lanoy, Sabrina Aziez, Oulimata Dieng, Mickael Andraud, Sophie Guillerm, Anthony Canellas, Baptiste Abbar, Elisabeth Fabre, Valérie Gounant, Etienne Giroux-Leprieur, Guillaume Chassagnon, Catherine Durdux, Marie Wislez

Читать у издателя →

Похожие статьи